In the past and present there have been times that the reliance on the
imports of China have cost the end-use industries dear and for several
intermediates and fine chemicals globally the closure of several units
in China had led to soaring prices and have also caused delays and
disruptions to production which was schedules here. According to one of
researched report, the pharmaceutical industries in India have time and again
been grieved, as the susceptibility to imported raw materials such as active
pharmaceutical ingredients (APIs) and their intermediates are mostly from China.
Moreover, squirts in prices were recently seen in some naphthalene-based
dye intermediates like H acid and in China its derivatives was attributed to
closure of several manufacturing units.
As per the industry experts, to the chemical industry or to India the dependence
on China for import of key raw materials is not only one of its kind and nowadays
in the global market, China controls more than 80%. However, the reliance on
imports from China is a contemplation of the developments in that country and to
create an enabling framework the changes in the Indian pharmaceutical,
agrochemical industries and the collective failure of policy makers are here,
which will look after a much larger Indian fine chemicals industry.
As per the researched report, the shift in focus of several majors in pharmaceutical
and agrochemical markets of India is one of the major reasons for the growing
role for Chinese producers in these two industries. Nevertheless, for APIs, technical
agrochemicals and their intermediates most of the Indian producers have
evacuate their manufacturing base in order to focus on the part of the value
chain which will bring them the best value.
On the other hand the leading Indian pharma companies have still continue
to make APIs and have got lot more careful about their product line up and have
opt to outsource or import the rest. Similarly, leading companies in
agrochemicals are also putting more awareness to get their products registered
and acknowledged amid farmers.
However the sway of China as a supplier of key raw
materials not just to India but to the global pharmaceutical industry is
dubious to moderate sooner, in spite of anxiety expressed on this count.
Follows us:
No comments:
Post a Comment